New structural details of the COVID-19 virus revealed

NewsGuard 100/100 Score

A new study led by Worcester Polytechnic Institute (WPI) brings into sharper focus the structural details of the COVID-19 virus, revealing an elliptical shape that "breathes," or changes shape, as it moves in the body. The discovery, which could lead to new antiviral therapies for the disease and quicker development of vaccines, is featured in the April edition of the peer-reviewed Cell Press structural biology journal Structure.

"This is critical knowledge we need to fight future pandemics," said Dmitry Korkin, Harold L. Jurist '61 and Heather E. Jurist Dean's Professor of Computer Science and lead researcher on the project. "Understanding the SARS-COV-2 virus envelope should allow us to model the actual process of the virus attaching to the cell and apply this knowledge to our understanding of the therapies at the molecular level. For instance, how can the viral activity be inhibited by antiviral drugs? How much antiviral blocking is needed to prevent virus-to-host interaction? We don't know. But this is the best thing we can do right now-;to be able to simulate actual processes."

Feeding genetic sequencing information and massive amounts of real-world data about the pandemic virus into a supercomputer in Texas, Korkin and his team, working in partnership with a group led by Siewert-Jan Marrink at the University of Groningen, Netherlands, produced a computational model of the virus's envelope, or outer shell, in "near atomistic detail" that had until now been beyond the reach of even the most powerful microscopes and imaging techniques.

Essentially, the computer used structural bioinformatics and computational biophysics to create its own picture of what the SARS-COV-2 particle looks like. And that picture showed that the virus is more elliptical than spherical and can change its shape. Korkin said the work also led to a better understanding of the M proteins in particular: underappreciated and overlooked components of the virus's envelope.

The M proteins form entities called dimers with a copy of each other, and play a role in the particle's shape-shifting by keeping the structure flexible overall while providing a triangular mesh-like structure on the interior that makes it remarkably resilient, Korkin said. In contrast, on the exterior, the proteins assemble into mysterious filament-like structures that have puzzled scientists who have seen Korkin's results, and will require further study.

Korkin said the structural model developed by the researchers expands what was already known about the envelope architecture of the SARS-COV-2 virus and previous SARS- and MERS-related outbreaks. The computational protocol used to create the model could also be applied to more rapidly model future coronaviruses, he said. A clearer picture of the virus' structure could reveal crucial vulnerabilities.

The envelope properties of SARS-COV-2 are likely to be similar to other coronaviruses. Eventually, knowledge about the properties of coronavirus membrane proteins could lead to new therapies and vaccines for future viruses."

Dmitry Korkin

The new findings published in Structure were three years in the making and built upon Korkin's work in the early days of the pandemic to provide the first 3D roadmap of the virus, based on genetic sequence information from the first isolated strain in China.

Journal reference:

Pezeshkian, W., et al. (2023). Molecular architecture and dynamics of SARS-CoV-2 envelope by integrative modeling. Structure.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
LVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variants